Lidia Fonseca - 25 Feb 2026 Form 4 Insider Report for PFIZER INC (PFE)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 Feb 2026, 18:34:06 UTC
Prior SEC filing
30 Apr 2025
Next SEC filing
05 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Shanice A. Reid, by power of atty, for Lidia Fonseca

Key filing fact

Lidia Fonseca filed Form 4 for PFIZER INC (PFE) on 27 Feb 2026.

Key facts

  • This page summarizes Lidia Fonseca's Form 4 filing for PFIZER INC (PFE).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 27 Feb 2026, 18:34.

Change

  • Previous filing in this sequence was filed on 30 Apr 2025.
  • Current net transaction value: +$439,834.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001454944 Primary reporting owner

Fonseca Lidia

Relationship
Executive Vice President
Address
66 HUDSON BOULEVARD EAST, ATTN: CORPORATE SECRETARY, NEW YORK
Signature
/s/ Shanice A. Reid, by power of atty, for Lidia Fonseca
Signature date
27 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PFE transaction

Common Stock

Options Exercise

Transaction value
$1,923,952
Shares
+56,888
Change %
+127%
Price
$33.82
Shares after
101,579
Date
25 Feb 2026
Ownership
Direct
Footnotes
F1
PFE transaction

Common Stock

Tax liability

Transaction value
$28,661
Shares
-1,058
Change %
-1%
Price
$27.09
Shares after
100,521
Date
25 Feb 2026
Ownership
Direct
Footnotes
F2
PFE transaction

Common Stock

Tax liability

Transaction value
$1,455,457
Shares
-54,066
Change %
-54%
Price
$26.92
Shares after
46,455
Date
25 Feb 2026
Ownership
Direct
Footnotes
F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PFE transaction Derivative

Stock Appreciation Rights

Options Exercise

Transaction value
$0
Shares
-56,888
Change %
-100%
Price
$0.000000
Shares after
0
Date
25 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
56,888
Exercise price
$33.82
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).

Footnote F2

The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.

Footnote F3

The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).

Footnote F4

Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .